CAMP4 Therapeutics Corp
NASDAQ:CAMP

Watchlist Manager
CAMP4 Therapeutics Corp Logo
CAMP4 Therapeutics Corp
NASDAQ:CAMP
Watchlist
Price: 6.21 USD -12.9% Market Closed
Market Cap: 291.1m USD

Operating Margin
CAMP4 Therapeutics Corp

-1 402.2%
Current
-3 949%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 402.2%
=
Operating Profit
-53.3m
/
Revenue
3.8m

Operating Margin Across Competitors

No Stocks Found

CAMP4 Therapeutics Corp
Glance View

Market Cap
291.1m USD
Industry
Biotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company is headquartered in Cambridge, Massachusetts and currently employs 53 full-time employees. The company went IPO on 2024-10-11. The company is leveraging its RAP Platform to advance a pipeline of programs initially focused on metabolic and central nervous system (CNS) disorders with validated disease biology and potential market opportunities due to the significant unmet need of affected patients. Its lead product candidate, CMP-CPS-001, has the potential to be the first disease-modifying therapy for the treatment of urea cycle disorders. CMP-CPS-001 is designed to improve urea cycle activity by amplifying expression of CPS1, a key enzyme that catalyzes the first step of the urea cycle, by binding to a CPS1-specific regRNA. Its CNS development program, CMP-SYNGAP, is focused on addressing the underlying cause of SYNGAP1-related disorders.

CAMP Intrinsic Value
0.25 USD
Overvaluation 96%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 402.2%
=
Operating Profit
-53.3m
/
Revenue
3.8m
What is the Operating Margin of CAMP4 Therapeutics Corp?

Based on CAMP4 Therapeutics Corp's most recent financial statements, the company has Operating Margin of -1 402.2%.

Back to Top